Pierre Gravier - 13 Jul 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol: PTCT
Transactions as of: 13 Jul 2023
Net transactions value: $0
Form type: 4
Filing time: 17 Jul 2023, 16:51:51 UTC
Next filing: 07 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTCT	Common Stock	Award	$0	+26,000		$0.000000	26,000	13 Jul 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTCT	Stock Option (Right to Buy)	Award	$0	+65,000		$0.000000	65,000	13 Jul 2023	Common Stock	65,000	$39.82	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on July 13, 2023 that vest in four equal installments over four years, commencing on July 13, 2024.
F2	This option was granted on July 13, 2023, and vests over four years, with 25% of the shares underlying the option vesting on July 13, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on October 13, 2024.